Foszfát diabetes aduittreatment, HUA2 - Egy koleszterinszint-csökkentő szer felhasználása - Google Patents
HUA2 - Egy koleszterinszint-csökkentő szer felhasználása - Google Patents
Rosivall L, Kiss I. Elmélet és klinikum, dialysis, transplantatio. Budapest: Medintel Könyvkiadó; Szakmai irányelvek és a klinikai gyakorlat: a csont- és ásványianyagcsere-betegség klinikai auditja felnôtt dializált betegekben Magyarországon.
Kidney International ; Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant ; Increased risk of hip fracture among patients with end-stage renal disease.
Csontelváltozás és lágyrész-kalcifikáció elôfordulása és meghatározó faktorai dializált betegekben
Kidney International, Vol. Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Mechanisms of vascular calcification in chronic kidney disease. J Am Soc Nephrol ; Arterial stiffness, vascular calcification and bone foszfát diabetes aduittreatment in chronic kidney disease.
World J Nephrol ;1 1 Association between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease. Pulse wave velocity is inversely related to vertebral bone density in hemodialysis patients.
Hypertension ; Calcaneal osteopenia is a new marker for arterial stiffness in chronic hemodialysis patients. Am J Nephrol ;25 3 Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis.
Department of Internal Medicine
N Engl J Med ; Vascular calcification, vertebral fractures and mortality in haemodialysis patients. Increased risk of mortality associated with hip fracture in the dialysis population.
Am J Kidney Dis ; The foszfát diabetes aduittreatment between osteoporosis and aortic calcification. Br J Radiol ; Calcified atherosclerotic plaque and bone mineral density in type 2 diabetes: The Diabetes Heart Study.
HU0105019A2 - Egy koleszterinszint-csökkentő szer felhasználása - Google Patents
Bone ;42 1 Metacarpal cortical area and risk of coronary heart disease. The Framingham Study.
Am J Epidemiol ; Relationship between bone mineral density and myocardial infarction in US adults. Osteoporosis Int ; Electron beam computed tomography foszfát diabetes aduittreatment the evaluation of cardiac calcifications in chronic dialysis patients. Coronary calcification in hemodialysis patients: the contribution of traditional and uremia-related risk factors.
HUA2 - Use of cholesterol-lowering agent - Google Patents
Is coronary artery calcification associated with vertebral bone density in nondialyzed chronic kidney disease patients? Clin J Am Soc Nephrol ; Moe SM. Vascular calcification and renal osteodystrophy relationship in chronic kidney disease.
Eur J Clin Invest ;36 Suppl. Brandenburg VM, Floege J. Foszfát diabetes aduittreatment bone disease — bone and beyond.
Forum Diabetes Sanatorium
NDT Plus ; Diagnostic accuracy of serum parathyroid hormon levels in kidney transplant recipiens with moderateto-advanced CKD. Nephron Clin Pract ; 2 :cc Vascular calcification is associated with cortical bone loss in chronic renal failure rats with and without ovariectomy: the calcification paradox. Am J Nephrol ; PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis.
Am J Kidney Dis ; Risk factors for vertebral fractures in renal osteodystrophy. Coco M, Rush H. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease. Kidney Int ;44 5 Arterial calcifications and bone histomorphometry in end-stage renal disease.
Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. J Am Soc Nephrol ;19 9 Low bone volume — a risk factor for coronary calcifications in hemodialysis patients.
HU0105019A2 - Use of cholesterol-lowering agent - Google Patents
Are PTH serum levels predictive of coronary calcifications in haemodialysis patients? Calcific uremic arteriolopathy in association with low turnover uremic bone disease. Clin Nephrol ; Kidney Int ; Aortic calcification and the risk of osteoporosis and fractures. J Clin Endocrinol Metab ; Progression of aortic calcification is associatiated with metacarpal bone loss during menopause.
A populationbased longitudinal study. Thromb Vasc Biol ; Clinical epidemiology of cardiovascular disease in chronic renal disease. Association between vascular calcification, arterial stiffness and bone mineral density in chronic hemodialysis patients.
Document 12003T/TXT
Geriatr Gerontol Int ; The connections between vascular cukorbetegség és szex and bone health. Kidney International Vol 76, SupplementumAug A krónikus vesebetegségben kialakuló csont és ásványianyagcserezavar vizsgálata és kezelése. Útmutató — Klinikai Irányelvek Kézikönyve, Nefrológia, Cardiovascular disease and bone.
Archives of Biochemistry and Biophysics ; Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia. Curr Opin Nephrol Hypertens ; Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population.
EUR-Lex - T/TXT - EN - EUR-Lex
Association of changes in bone remodeling and coronary calcification in hemodialysis patients: a prospective study. Lakatos P, Takács I. A csontanyagcsere betegségei.
Slovenia 35,64 35,63 35,63 Slovakia 15,94 15,93 15,93 3. The beneficiary Member States shall be responsible for selecting and implementing individual operations in compliance with this Article.
Budapest: Semmelweis Kiadó; Bone mineral density in patients on maintenance dialysis. Int Urol Nephrol ; Evidence for preservation of cortical bone mineral density in patients on continuous ambulantory peritoneal dialysis. J Bone Miner Res ;
